Mental Disorders

Pipeline Programs

Companies

Clinical Trials

Approved Products

Pipeline by Development Stage

Preclinical

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

On Market

Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

8 companies ranked by most advanced pipeline stage

Pre

P1/2

P2/3

Mkt

ViiV HealthcareNC - Durham

8 programs

paroxetinePhase 4

Cherry lamotrigine ODTPhase 1

DrugPhase 1

LamotriginePhase 1

Lamotrigine IR tabletsPhase 1

+3 more programs

Yuyu PharmaKorea - Seoul

2 programs

YY-162Phase 31 trial

Active Trials

NCT01536210Completed144Est. Dec 2012

NCT01201187Completed144Est. Apr 2011

GSKLONDON, United Kingdom

7 programs

ParoxetineN/A1 trial

DrugPHASE_11 trial

LamotriginePHASE_11 trial

+2 more programs

Active Trials

NCT01371448Completed339Est. Sep 2005

NCT01371461Completed390Est. Oct 2004

NCT01371435Completed3,708Est. Dec 2005

+4 more trials

Angeles TherapeuticsCA - Los Angeles

2 programs

Psychosocial Weight InterventionN/A1 trial

eWellnessN/A1 trial

Active Trials

NCT02183844Completed61Est. Oct 2017

NCT01324973Completed60Est. Apr 2014

Alliance PharmaceuticalsUK - Wiltshire

1 program

Integrated Collaborative Care TeamN/A1 trial

Active Trials

NCT02836080Active Not Recruiting247Est. Apr 2026

Bristol Myers SquibbPRINCETON, NJ

1 program

Progressive Goal Attainment ProgramN/A1 trial

Active Trials

NCT01565863Completed199Est. Nov 2013

Verona PharmaUK - London

1 program

PsychotherapyN/A1 trial

Active Trials

NCT02700490Completed400Est. Dec 2018

Innovation PharmaceuticalsMA - Wakefield

1 program

Recovery RoadmapN/A1 trial

Active Trials

NCT02707367Completed127Est. Jun 2020

Trial Timeline

Clinical trial activity over time

2021

2022

2023

2024

2025

2026

GSKparoxetine

Yuyu PharmaYY-162

GSKDrug

GSKLamotrigine IR tablets

GSKLamotrigine

Innovation PharmaceuticalsRecovery Roadmap

Verona PharmaPsychotherapy

Alliance PharmaceuticalsIntegrated Collaborative Care Team

Angeles TherapeuticsPsychosocial Weight Intervention

Angeles TherapeuticseWellness

Bristol Myers SquibbProgressive Goal Attainment Program

GSKParoxetine

Clinical Trials (15)

Total enrollment: 6,294 patients across 15 trials

NCT00259883 GSKparoxetine

Combination Of PAXIL Tablet And Benzodiazepines

Start: Jun 2005Est. completion: Feb 2006150 patients

Phase 4Completed

NCT01536210 Yuyu PharmaYY-162

Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract in Children With ADHD(Attention Deficit Hyperactivity Disorder)

Start: Dec 2011Est. completion: Dec 2012144 patients

Phase 3Completed

NCT01201187 Yuyu PharmaYY-162

Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract(YY-162)in Children With ADHD

Start: Mar 2010Est. completion: Apr 2011144 patients

Phase 3Completed

NCT01371799 GSKDrug

A Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy Smokers

Start: Dec 2009Est. completion: Jun 20109 patients

Phase 1Completed

NCT00449774 GSKLamotrigine IR tablets

Bioequivalence And Effect Of Food And Water On Lamotrigine in Healthy Volunteers

Start: May 2007Est. completion: Jun 2007220 patients

Phase 1Completed

NCT00410371 GSKLamotrigine

Study to Compare Two Formulations of Lamotrigine in Healthy Subjects

Start: Dec 2006Est. completion: Jan 200796 patients

Phase 1Completed

NCT02707367 Innovation PharmaceuticalsRecovery Roadmap

Recovery Roadmap Phase II Small Business Innovation Research Grant

Start: Jun 2017Est. completion: Jun 2020127 patients

N/ACompleted

NCT02700490 Verona PharmaPsychotherapy

Evaluating the Clinical Cost-effectiveness of Two Primary Mental Health Service Frameworks in Yogyakarta, Indonesia

Start: Dec 2016Est. completion: Dec 2018400 patients

N/ACompleted

NCT02836080 Alliance PharmaceuticalsIntegrated Collaborative Care Team

Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)

Start: Sep 2016Est. completion: Apr 2026247 patients

N/AActive Not Recruiting

NCT02183844 Angeles TherapeuticsPsychosocial Weight Intervention

A System for Preference Assessment in Mental Health

Start: Jun 2014Est. completion: Oct 201761 patients

N/ACompleted

NCT01324973 Angeles TherapeuticseWellness

Web-Based Weight Management for Individuals With Mental Illness

Start: Mar 2012Est. completion: Apr 201460 patients

N/ACompleted

NCT01565863 Bristol Myers SquibbProgressive Goal Attainment Program

Progressive Goal Attainment Program for Veterans

Start: Feb 2012Est. completion: Nov 2013199 patients

N/ACompleted

NCT01371461 GSKParoxetine

Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)

Start: Jan 2004Est. completion: Oct 2004390 patients

N/ACompleted

NCT01371448 GSKParoxetine

Special Drug Use Investigation for PAXIL Tablet (Long-term)

Start: May 2001Est. completion: Sep 2005339 patients

N/ACompleted

NCT01371435 GSKParoxetine

Drug Use Investigation for PAXIL Tablet

Start: Apr 2001Est. completion: Dec 20053,708 patients

N/ACompleted

Phase Legend

Preclinical— Lab & animal studies

Phase 1— Safety & dosing

Phase 2— Efficacy testing

Phase 3— Large-scale trials

On Market— Approved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals

8 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.